- Revenues and grant income of
$54.6 million , compared to revenues and grant income of$21.5 million in 2Q 2025 - Entered long-term agreements for high-assay low-enriched uranium (“HALEU”) enrichment services with Centrus Energy Corp. and
General Matter - Announced agreement with
SGL Carbon to expand manufacturing capacity for nuclear-grade graphite - Received continuation application approval from the
U.S. Department of Energy's (“DOE”) Advanced Reactor Demonstration Program (“ARDP”), which extends its budget period throughMarch 2027 - Received
$11 million economic development grant from theState of Tennessee to support TRISO-X fuel fabrication campus inOak Ridge, Tennessee - Acquired ~70 acres of land adjacent to its commercial nuclear fuel fabrication campus in
Oak Ridge, Tennessee - Founding member of initiative to accelerate advanced nuclear deployment through the use of artificial intelligence with
Idaho National Laboratory (“INL”), NVIDIA, AWS and other partners - Extended advanced nuclear fuel research partnership to continue optimizing fuel fabrication with
Oak Ridge National Laboratory (“ORNL”)
“Our progress in the second quarter reflects our continued focus on execution across every part of our business,” said
“Overall, we believe this momentum only reinforces our ability to deliver for our customers and continues to build a moat between us and our competitors. We remain focused on building the technology delivery platform to help meet the demands for clean, reliable nuclear energy,” concluded Sell.
Operational Highlights
- Secures Strategic HALEU Enrichment Services: Executed commercial order for HALEU enrichment services, entering into long-term supply agreements with Centrus Energy Corp. and
General Matter to support the deployment of its commercial pipeline of Xe-100 SMRs. - Expands Joint Supply Chain for Key Reactor Material: Announced agreement to double SGL Carbon’s European production capacity for medium-grain isotropic graphite (“NBG-18”), a specialized material central to X-energy’s Xe-100 high-temperature gas-cooled reactor (“HTGR”). Under the agreement, among other terms, X-energy will invest up to
$8 million in milestone-based payments to support new molding facilities and furnace upgrades at SGL’s facility in Chedde,France . Full execution would double European manufacturing capacity for NBG-18 by 2030, enabling the facility to produce graphite billets for up to 8 new Xe-100 reactors per year. - Received Continuation Application Approval from the
DOE : X-energy has received formal approval of its ARDP continuation application for a budget period extension throughMarch 2027 . The ARDP provides X-energy with a 50/50 cost share to continue work toward design, licensing, commercialization, and construction of its first-of-a-kind commercial advanced nuclear plant in collaboration with Dow inSeadrift, Texas , and TX-1, its first commercial TRISO-X fuel fabrication facility. - TX-1 Vertical Construction Nears Completion: Vertical construction for the shell of the Company's TX-1 fuel facility in
Oak Ridge, Tennessee is progressing on schedule. The Company is on track to meet its near-term milestones for vertical construction completion and the commencement of support building and interior build-out, scheduled to begin in the third quarter of 2026 as planned. - TRISO-X Fuel and TX-1/TX-2 Continues to Accelerate: TRISO-X, a leading manufacturer of advanced nuclear fuels and wholly-owned subsidiary of X-energy, was awarded an
$11 million economic development grant from theState of Tennessee . The funding will support the continued development of the Company’s fuel fabrication campus inOak Ridge, Tennessee , including an expected second commercial fuel facility, TX-2, and a dedicated research and development center. The award demonstratesTennessee's continued support for TRISO-X’s efforts to build one of the world's largest TRISO fuel facility campuses.
In July, TRISO-X extended its relationship with theDOE's Oak Ridge National Laboratory through entry into a cooperative research and development agreement. This agreement expands upon a strategic collaboration that has played a central role in advancing commercial-scale TRISO fuel development and manufacturing since 2016. The 30-month agreement builds on nearly a decade of joint research, technology transfer, and process development that has enabled TRISO-X to transition to advance fuel manufacturing processes readiness to manufacture at commercial scale.
Also in July, the Company acquired approximately 70 acres of land adjacent to its commercial nuclear fuel campus inOak Ridge, Tennessee . This expansion supports the continued development of the Company’s fuel fabrication campus, increasing TRISO-X's footprint to approximately 180 acres and is covered under the NRC's Part 70 fuel fabrication license.
- Founding Member of
DOE's AI Initiative: The Company recently joined theDOE's Project Prometheus as a founding member, collaborating with organizations includingIdaho National Laboratory , Nvidia, andAmazon Web Services to accelerate advanced nuclear deployment through the use of artificial intelligence. The Company committed$10 million in private capital, along with the use of its Xe-100 HTGR design and fuel fabrication data. This data will serve as a technical platform for a three-year research campaign, leveraging the DOE’s test reactors and supercomputing capabilities to integrate frontier-class AI models into reactor design, licensing, manufacturing, construction, and semi-autonomous operation workflows, as well as fuel. - Strengthened Balance Sheet with Initial Public Offering (“IPO”) Net Proceeds: On
April 24, 2026 , the Company began trading on Nasdaq under the ticker “XE” and onApril 27, 2026 , the Company closed its IPO, raising approximately$1.1 billion in net proceeds.
Financial Results
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||
| (Dollars in millions) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||
| Total revenues and grant income | $ | 54.6 | $ | 21.5 | 154 | % | $ | 98.0 | $ | 42.3 | 132 | % | ||||||||||||
| Total operating expenses | 164.6 | 64.3 | 156 | % | 274.2 | 111.4 | 146 | % | ||||||||||||||||
| Net cash used in operating activities | (97.3 | ) | (20.0 | ) | 387 | % | (164.6 | ) | (61.8 | ) | 166 | % | ||||||||||||
| Net cash used in investing activities | (73.6 | ) | (17.0 | ) | 334 | % | (239.6 | ) | (18.7 | ) | 1,184 | % | ||||||||||||
| Net cash provided by (used in) financing activities | 1,092.3 | (0.5 | ) | 227,186 | % | 1,091.2 | 50.4 | 2,065 | % | |||||||||||||||
Total revenues and grant income in the three months ended
Total operating expenses in the three months ended
The increase in Direct costs was primarily driven by expanded activity under the ARDP Agreement. Subcontracting costs increased by
The increase in Selling, general, and administrative expenses was driven by an increase in non-cash equity-based and unit-based compensation expense of
Net cash used in operating activities in the six months ended
Net cash used in investing activities in the six months ended
Net cash provided by financing activities in the six months ended
Liquidity
| (Dollars in millions) | % Change | |||||||||||
| Cash and cash equivalents | $ | 1,145.4 | $ | 458.9 | 150 | % | ||||||
| Short-term investments | 489.8 | 304.9 | 61 | % | ||||||||
| Long-term investments | 264.6 | 261.5 | 1 | % | ||||||||
| Total liquidity | $ | 1,899.8 | $ | 1,025.3 | 85 | % | ||||||
Cash and cash equivalents totaled
Project Pipeline
The Company’s project pipeline consists of 144 reactors across the
Participation in Upcoming Investor Conferences
X-energy is scheduled to participate in the following events in September and
Wolfe Research Utilities , Midstream & Clean Energy Conference,September 30 ,New York, NY - Investing in Advanced Nuclear Energy,
October 1 ,New York, NY TD Cowen 11th Annual Nuclear Roundtable,October 8 , virtual
Conference Call
X-energy will host a conference call today at
About X-energy
X-energy is a leading designer of advanced small modular nuclear reactors (“SMR”) and fuel technology developed to establish a new standard in clean, safe, reliable energy. X-energy's intrinsically safe Xe-100 high-temperature gas-cooled reactor and TRISO-X particle fuel expand applications for nuclear technology, with commercial projects across grid, industrial, and AI. Together, X-energy's technology drives enhanced safety, lower cost, faster construction timelines, and scalable deployment when compared with other SMRs and conventional nuclear. For more information, visit X-energy.com or connect with us on X or LinkedIn.
Contacts
Investor Relations
Patricia Gil
+1 301.558.3040
investors@x-energy.com
Media
Robert McEntyre
+1 240.673.6565
media@x-energy.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. X-energy intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements can be identified by the fact they do not relate strictly to historical or current facts. Words such as “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words, or similar terms and phrases may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements relating to the Company’s strategic and operational plans, including plans with respect to construction and expansion of its fuel fabrication campus, expectations with respect to changes in ARDP, the Company’s ability to receive regulatory approvals and on accelerated timeframes, expected project deployment timelines, the Company’s ability to continue to execute its business plan, its ability to continue to reduce the risk of X-energy’s supply chain, expectations regarding future supply of graphite and HALEU from its suppliers, the success of the Company’s supply chain partnerships, future growth, and business outlook.
These forward-looking statements are neither promises nor guarantees and are subject to a number of risks, uncertainties, and assumptions. Actual results may differ materially as a result of a number of factors, including, without limitation, the Company’s ability to achieve final investment decisions from its customers; ability to realize its plans to deliver a commercial Xe-100; the Company’s projects may be subject to delays or setbacks; its liquidity and ability to raise capital; changes or delays in support from the U.S. government, including ARDP; changes, delays, or an inability to receive licenses or other governmental approvals necessary for X-energy’s reactors and fuel facilities; uncertainty and changes in expected costs, schedules and unit economics due to inflation; supply chain constraints (including access to HALEU, graphite and certain other materials), labor availability, site-specific factors and first-of-a-kind risks; suppliers inability to expand or develop capacity to supply X-energy or its customers; X-energy’s limited operating experience at intended scale and the possibility that latent design or operational issues may emerge; reliance on a limited number of specialized suppliers and exposure to supply disruptions, quality issues, and trade policy changes; safety, security, and cybersecurity incidents; the nascent and uncertain market adoption of SMRs and the possibility that demand may grow more slowly than expected or customers may defer or cancel projects; competition from competitors with potentially greater resources or lower costs; reliance on key partners and customers and the risk that changes in partner or customer priorities or timelines could materially affect commercialization; customer contractual terms that may constrain capacity allocation and compress margins; fuel business dependence on a limited number of suppliers for key materials; licensing and scaling X-energy’s fuel fabrication campus and the risk of delays in licensing or facility construction; changes in laws, regulations, incentives, energy market rules, export controls, or government policies; shifts in public perception and political support for nuclear energy or customers; dependence on key personnel and ability to hire and retain talent; and ability to obtain, maintain, or enforce IP rights. The foregoing list of factors is not exhaustive. Additional information concerning these and other factors can be found in the section entitled “Risk Factors” in X-energy’s most recent Form 10-Q filed with Securities and Exchange Commission ("SEC"), and in subsequent filings made with the SEC.
Caution must be exercised in relying on these and other forward-looking statements. Due to known and unknown risks, X-energy’s results may differ materially from its expectations and projections. Any forward-looking statements made herein speak only as of the date of this press release, and you should not rely on forward-looking statements as predictions of future events. Although X-energy believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the future results, performance or achievements reflected in the forward-looking statements will be achieved or will occur. Except as required by law, X-energy does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Non-GAAP Financial Measures
This press release presents information about certain non-GAAP financial measures. The non-GAAP financial measures are supplemental measures, are not defined by or presented in accordance with GAAP, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of X-energy’s financial results as reported under GAAP. A potential limitation of these non-GAAP financial measures is that other companies may report similar non-GAAP metrics, but calculate them differently, which reduces the usefulness of these non-GAAP metrics as a comparative measure. Because of this and other limitations, you should not consider the non-GAAP financial measures as a substitute for GAAP-based financial performance measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are provided herein.
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except unit and share data) (unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 1,145,424 | $ | 458,932 | ||||
| Short-term investments | 489,752 | 304,908 | ||||||
| Accounts receivable | 40,782 | 32,940 | ||||||
| Unbilled receivables and contract assets | 75,359 | 41,529 | ||||||
| Prepaid and other current assets | 21,302 | 11,491 | ||||||
| Due from related parties | 21,256 | 4,580 | ||||||
| Total current assets | 1,793,875 | 854,380 | ||||||
| Long-term investments | 264,634 | 261,458 | ||||||
| Restricted cash | 4,200 | 3,698 | ||||||
| Property and equipment, net | 119,126 | 50,105 | ||||||
| Operating lease right-of-use assets | 21,750 | 22,696 | ||||||
| Other long-term assets | 51,626 | 18,934 | ||||||
| Total assets | $ | 2,255,211 | $ | 1,211,271 | ||||
| LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY AND MEMBERS’ DEFICIT | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | 10,700 | $ | 3,363 | ||||
| Accrued liabilities | 86,142 | 51,217 | ||||||
| Due to related parties | 7,466 | 4,225 | ||||||
| Total current liabilities | 104,308 | 58,805 | ||||||
| Long-term deferred revenue | 12,800 | 12,800 | ||||||
| Long-term deferred revenue with related parties | 17,527 | 2,353 | ||||||
| Long-term operating lease liabilities | 24,929 | 20,887 | ||||||
| Warrant liabilities | — | 274,166 | ||||||
| Total liabilities | 159,564 | 369,011 | ||||||
| Mezzanine equity | ||||||||
| Class A and B common units?¹? | — | 95,153 | ||||||
| Series A, A-1, | — | 1,971,402 | ||||||
| Total mezzanine equity | — | 2,066,555 | ||||||
| Preferred Stock: | — | — | ||||||
| Class A common stock: | 29 | — | ||||||
| Class B common stock: | 12 | — | ||||||
| Accumulated deficit | (59,090 | ) | (1,236,345 | ) | ||||
| Accumulated other comprehensive income (loss) | 306 | (117 | ) | |||||
| Additional paid-in capital | 1,873,512 | 12,167 | ||||||
| Total equity (deficit) attributable to | 1,814,769 | (1,224,295 | ) | |||||
| Non-controlling interests | 280,878 | — | ||||||
| Total stockholders’ equity and members’ deficit | 2,095,647 | (1,224,295 | ) | |||||
| Total liabilities, mezzanine equity, and stockholders’ equity and members’ deficit | $ | 2,255,211 | $ | 1,211,271 | ||||
| (1) | See Note 10 — Stockholders’ Equity and Mezzanine Equity to the condensed consolidated financial statements in the Company's Quarterly Report on Form 10-Q for the period ended | |||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (in thousands, except share and per share amounts) (unaudited) | ||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Services revenue(1) | $ | 50,119 | $ | 16,919 | $ | 90,025 | $ | 34,010 | ||||||||
| Grant income | 4,482 | 4,585 | 7,999 | 8,298 | ||||||||||||
| Total revenues and grant income | 54,601 | 21,504 | 98,024 | 42,308 | ||||||||||||
| Operating expenses | ||||||||||||||||
| Direct costs | 86,658 | 36,129 | 152,017 | 64,853 | ||||||||||||
| Selling, general and administrative | 77,733 | 27,347 | 121,850 | 45,327 | ||||||||||||
| Research and development | 244 | 808 | 299 | 1,210 | ||||||||||||
| Total operating expenses | 164,635 | 64,284 | 274,166 | 111,390 | ||||||||||||
| Operating loss | (110,034 | ) | (42,780 | ) | (176,142 | ) | (69,082 | ) | ||||||||
| Other income (expense) | ||||||||||||||||
| Interest expense | — | (360 | ) | — | (484 | ) | ||||||||||
| Interest income | 11,013 | 4,980 | 19,942 | 10,457 | ||||||||||||
| Other income (expense), net | (6,312 | ) | (50,688 | ) | (115,350 | ) | (39,951 | ) | ||||||||
| Total other income (expense), net | 4,701 | (46,068 | ) | (95,408 | ) | (29,978 | ) | |||||||||
| Net loss | (105,333 | ) | (88,848 | ) | (271,550 | ) | (99,060 | ) | ||||||||
| Less: Net loss attributable to non-controlling interests | (46,243 | ) | (88,848 | ) | (212,460 | ) | (99,060 | ) | ||||||||
| Net loss attributable to | $ | (59,090 | ) | $ | — | $ | (59,090 | ) | $ | — | ||||||
| Net loss attributable to Class A common stock per share, basic and diluted(2) | $ | (0.21 | ) | N/A | $ | (0.21 | ) | N/A | ||||||||
| Weighted-average shares of Class A common stock outstanding, basic and diluted(2) | 280,148,818 | N/A | 280,148,818 | N/A | ||||||||||||
| Other comprehensive income (loss) | ||||||||||||||||
| Foreign currency translation adjustment | 410 | (766 | ) | 553 | (976 | ) | ||||||||||
| Changes in fair value of liabilities under fair value option attributable to changes in instrument-specific credit risk | — | 291 | — | 444 | ||||||||||||
| Other comprehensive income (loss) | 410 | (475 | ) | 553 | (532 | ) | ||||||||||
| Comprehensive loss | (104,923 | ) | (89,323 | ) | (270,997 | ) | (99,592 | ) | ||||||||
| Less: Comprehensive loss attributable to non-controlling interests | (46,179 | ) | (89,323 | ) | (212,253 | ) | (99,592 | ) | ||||||||
| Comprehensive loss attributable to | $ | (58,744 | ) | $ | — | $ | (58,744 | ) | $ | — | ||||||
| (1) | Includes related party revenue of | ||||||||
| (2) | Basic and diluted net loss per Class A common stock is presented only for the period after the Company’s reorganization transactions. See Note 1 — Organization and Nature of Business and Note 12 — Net Loss per Share to the condensed consolidated financial statements in the Company's Quarterly Report on Form 10-Q for the period ended | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (unaudited) | ||||||||
| Six Months Ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (271,550 | ) | $ | (99,060 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 1,090 | 550 | ||||||
| Equity-based and unit-based compensation | 43,926 | 6,424 | ||||||
| Mark-to-market loss on warrant liabilities | 114,473 | 39,540 | ||||||
| Mark-to-market loss on C-2 Notes | — | 1,363 | ||||||
| Accretion and amortization on investments | (2,249 | ) | — | |||||
| Amortization of deferred financing costs, debt discount, and other | — | 489 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable and unbilled receivables | (24,279 | ) | (7,135 | ) | ||||
| Prepaid and other current assets | (10,771 | ) | (6,270 | ) | ||||
| Due from related parties | (16,675 | ) | 10,105 | |||||
| Operating lease right-of use assets | 4,413 | (1,634 | ) | |||||
| Accounts payable and accrued liabilities | 10,754 | (4,127 | ) | |||||
| Long-term deferred revenue with related parties | 15,174 | — | ||||||
| Accrued interest receivable | (163 | ) | — | |||||
| Other long-term assets | (32,564 | ) | (394 | ) | ||||
| Due to related parties | 3,239 | (194 | ) | |||||
| Operating lease liabilities | 614 | (1,496 | ) | |||||
| Net cash used in operating activities | $ | (164,568 | ) | $ | (61,839 | ) | ||
| Cash flows from investing activities: | ||||||||
| Capital expenditures | (106,266 | ) | (35,587 | ) | ||||
| Reimbursement of capital expenditures under government grant | 52,261 | 16,920 | ||||||
| Purchase of investments | (316,468 | ) | — | |||||
| Proceeds from maturities on investments | 130,858 | — | ||||||
| Net cash used in investing activities | $ | (239,615 | ) | $ | (18,667 | ) | ||
| Cash flows from financing activities: | ||||||||
| Payments of mezzanine equity issuance costs | — | (2,525 | ) | |||||
| Payment of debt issuance costs | — | (497 | ) | |||||
| Payment of transaction costs | (12,499 | ) | — | |||||
| Proceeds from issuance of Preferred Units | 500 | 53,424 | ||||||
| Proceeds from initial public offering, net of underwriting costs | 1,103,235 | — | ||||||
| Net cash provided by financing activities | $ | 1,091,236 | $ | 50,402 | ||||
| Net effect of exchange rate | (59 | ) | 127 | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 686,994 | (29,977 | ) | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | 462,630 | 514,600 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 1,149,624 | $ | 484,623 | ||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (in thousands, except share and per share data) | ||||||||||||||||
| Adjusted Net Loss, Fully Diluted Share Count, and Adjusted Net Loss per Share, Diluted Non-GAAP fully diluted share count is defined as the weighted average of Class A common stock outstanding for the period reported if (i) all of the holders of Management uses these non-GAAP financial measures to evaluate potential shareholder dilution, facilitate period-over-period comparability, and support internal planning and capital allocation. Management believes they provide investors useful supplemental information. Non-GAAP fully diluted share count helps investors assess the potential impact on the Company's capital structure of outstanding XERC Common Units redeemable for Class A common stock (with an equal number of Class B common stock cancelled) and equity awards, while Adjusted net loss and Adjusted net loss per share, diluted aid period-to-period comparisons by excluding certain non-cash items that may obscure underlying operating trends. Including net loss attributable to non-controlling interests enables investors to evaluate the operating results of the Company’s consolidated business without regard to its ownership structure. | ||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Numerator: | ||||||||||||||||
| Net loss attributable to | $ | (59,090 | ) | $ | — | $ | (59,090 | ) | $ | — | ||||||
| Net loss attributable to | (21,159 | ) | (88,848 | ) | (187,376 | ) | (99,060 | ) | ||||||||
| Net loss attributable to non-controlling interests subsequent to the IPO | (25,084 | ) | — | (25,084 | ) | — | ||||||||||
| Net loss | $ | (105,333 | ) | $ | (88,848 | ) | $ | (271,550 | ) | $ | (99,060 | ) | ||||
| Adjustments: | ||||||||||||||||
| Equity-based and unit-based compensation | 39,661 | 6,358 | 43,926 | 6,424 | ||||||||||||
| Mark-to-market loss on warrant liabilities and C-2 Notes | 5,574 | 51,484 | 114,473 | 40,903 | ||||||||||||
| Adjusted net loss | $ | (60,098 | ) | $ | (31,006 | ) | $ | (113,151 | ) | $ | (51,733 | ) | ||||
| Denominator: | ||||||||||||||||
| Weighted average shares of Class A common stock outstanding, basic and diluted | 280,148,818 | N/A | 280,148,818 | N/A | ||||||||||||
| Adjustments: | ||||||||||||||||
| Shares of Class B common stock outstanding(1) | 118,907,377 | N/A | 118,907,377 | N/A | ||||||||||||
| Vested and unvested stock options outstanding | 7,566,848 | N/A | 7,566,848 | N/A | ||||||||||||
| Unvested Restricted Stock Awards and Restricted Stock Units | 7,531,628 | N/A | 7,531,628 | N/A | ||||||||||||
| Fully diluted share count(2) | 414,154,671 | N/A | 414,154,671 | N/A | ||||||||||||
| Net loss per share, diluted(3) | $ | (0.21 | ) | N/A | $ | (0.21 | ) | N/A | ||||||||
| Adjusted net loss per share, diluted(4) | $ | (0.15 | ) | N/A | $ | (0.27 | ) | N/A | ||||||||
| (1) | Holders of shares of Class B common stock hold an equal number of XERC Common Units (as defined in the condensed consolidated financial statements in the Company's Quarterly Report on Form 10-Q for the period ended | ||||||||
| (2) | The Company currently has a warrant outstanding that is exercisable for 14.1 million shares contingent upon future events or performance conditions. This warrant is not currently included in the fully diluted share count as it was not deemed probable of vesting as of | ||||||||
| (3) | Net loss per share, diluted is calculated by dividing the Net loss attributable to | ||||||||
| (4) | Adjusted net loss per share, diluted is calculated by dividing Adjusted net loss by the fully diluted share count. | ||||||||
Adjusted EBITDA
Earnings Before Interest, Income Taxes, Depreciation and Amortization (“EBITDA”) adjusts Net loss attributable to
Adjusted EBITDA is EBITDA excluding (i) equity-based and unit-based compensation and (ii) mark-to-market loss on warrant liabilities and C-2 Notes. Adjusted EBITDA is used by management to assess the Company’s operating performance. Management believes these adjustments exclude variables unrelated to the Company’s core operations and allow for meaningful comparisons between the Company’s operating results from period to period.
| Three Months Ended | Six Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net loss attributable to | $ | (59,090 | ) | $ | — | $ | (59,090 | ) | $ | — | ||||||
| Net loss attributable to XERC prior to the IPO | (21,159 | ) | (88,848 | ) | (187,376 | ) | (99,060 | ) | ||||||||
| Net loss attributable to non-controlling interests subsequent to the IPO | (25,084 | ) | — | (25,084 | ) | — | ||||||||||
| Net loss | (105,333 | ) | (88,848 | ) | (271,550 | ) | (99,060 | ) | ||||||||
| Adjustments: | ||||||||||||||||
| Interest expense | — | 360 | — | 484 | ||||||||||||
| Interest income | (11,013 | ) | (4,980 | ) | (19,942 | ) | (10,457 | ) | ||||||||
| Income tax expense | — | — | — | — | ||||||||||||
| Depreciation and amortization | 639 | 324 | 1,090 | 550 | ||||||||||||
| EBITDA | $ | (115,707 | ) | $ | (93,144 | ) | $ | (290,402 | ) | $ | (108,483 | ) | ||||
| Adjustments: | ||||||||||||||||
| Equity-based and unit-based compensation | 39,661 | 6,358 | 43,926 | 6,424 | ||||||||||||
| Mark-to-market loss on warrant liabilities and C-2 Notes | 5,574 | 51,484 | 114,473 | 40,903 | ||||||||||||
| Adjusted EBITDA | $ | (70,472 | ) | $ | (35,302 | ) | $ | (132,003 | ) | $ | (61,156 | ) | ||||
Source: